Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell?
- PMID: 16076967
- PMCID: PMC1734201
- DOI: 10.1136/jme.2003.007302
Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell?
Abstract
Telling people that they have cancer has a great impact on their lives, so many doctors are concerned about how they should inform patients about a cancer diagnosis and its prognosis. We conducted a general population survey in Japan to investigate people's preferences on receiving this information. There were no significant differences in respondents' preferences according to the seriousness of the cancer. Full disclosure of the diagnosis was preferred by 86.1% of the respondents, while 2.7% wanted non-disclosure. As for the initial provision of information, the majority preferred partial disclosure concerning the prospects of complete recovery (64.5%) and the expected length of survival (64.1%). Those who responded negatively to the statement, "If I am close to the end of my life, I want to be informed of the fact so I can choose my own way of life", were more likely to want non-disclosure on diagnosis. The results suggest that, at the first opportunity of providing information, a disclosure policy of giving patients full details of their diagnosis and some information on prognosis can satisfy the preferences of most patients. Contrary to popular belief, the seriousness of the cancer and people's demographic characteristics displayed little impact in this study.
Similar articles
-
Disclosure of cancer diagnosis and prognosis: a survey of the general public's attitudes toward doctors and family holding discretionary powers.BMC Med Ethics. 2004 Dec 1;5:E7. doi: 10.1186/1472-6939-5-7. BMC Med Ethics. 2004. PMID: 15571636 Free PMC article.
-
Informing patients about cancer in Nepal: what do people prefer?Palliat Med. 2006 Jun;20(4):471-6. doi: 10.1191/0269216306pm1154oa. Palliat Med. 2006. PMID: 16875119
-
Disclosure of cancer diagnosis and prognosis by physicians in Kuwait.Int J Clin Pract. 2002 Apr;56(3):215-8. Int J Clin Pract. 2002. PMID: 12018829
-
Not telling the truth: circumstances leading to concealment of diagnosis and prognosis from cancer patients.Eur J Cancer Care (Engl). 2010 Sep;19(5):589-93. doi: 10.1111/j.1365-2354.2009.01100.x. Epub 2009 Dec 3. Eur J Cancer Care (Engl). 2010. PMID: 20030693 Review.
-
Cross-cultural issues in the disclosure of cancer.Cancer Pract. 1998 May-Jun;6(3):153-60. doi: 10.1046/j.1523-5394.1998.006003153.x. Cancer Pract. 1998. PMID: 9652246 Review.
Cited by
-
Survey of the general public's attitudes toward advance directives in Japan: how to respect patients' preferences.BMC Med Ethics. 2006 Oct 18;7:E11. doi: 10.1186/1472-6939-7-11. BMC Med Ethics. 2006. PMID: 17044943 Free PMC article.
-
An Exploratory Study on Information Manipulation by Doctors: Awareness, Actual State, and Ethical Tolerance.Clin Pract. 2022 Sep 8;12(5):723-733. doi: 10.3390/clinpract12050075. Clin Pract. 2022. PMID: 36136869 Free PMC article.
-
Communication patterns in the doctor-patient relationship: evaluating determinants associated with low paternalism in Mexico.BMC Med Ethics. 2020 Dec 10;21(1):125. doi: 10.1186/s12910-020-00566-3. BMC Med Ethics. 2020. PMID: 33302932 Free PMC article.
-
Is It Worth Knowing That You Might Die Tomorrow? Revisiting the Ethics of Prognosis Disclosure.Clin Pract. 2022 Oct 4;12(5):803-808. doi: 10.3390/clinpract12050084. Clin Pract. 2022. PMID: 36286070 Free PMC article.
-
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review.Br J Cancer. 2018 Nov;119(10):1288-1296. doi: 10.1038/s41416-018-0305-5. Epub 2018 Oct 24. Br J Cancer. 2018. PMID: 30353050 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials